Search clinical trials for: Psoriasis,

Total 2308 results

University Hospital, Ghent

Completed

Therapeutic Drug Monitoring of Adalimumab in Psoriasis Patients

Psoriasis

Belgium
Eli Lilly and Company

Completed

A Study of LY3361237 in Participants With Psoriasis

Psoriasis

Poland, Hungary, Bulgaria, Slovakia
AbbVie

Completed

A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

Brazil
Bristol-Myers Squibb

Completed

An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis

Psoriasis

Japan
Galderma R&D

Completed

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Psoriasis

United States
Aswan University Hospital

Active, not recruiting

Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis

Psoriasis

Egypt
Bristol-Myers Squibb

Completed

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment (DCE)

Psoriasis

United States
Dr. Reddy's Laboratories Limited

Completed

A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)

Psoriasis

United States
Organon and Co

Completed

Elocon vs Fluticasone in Localized Psoriasis (P03197)

Psoriasis
Janssen-Cilag Ltd.

Completed

A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis (G-PLUS)

Psoriasis

Germany, France, Italy, Spain, United Kingdom
Aswan University Hospital

Unknown

Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis

Psoriasis

Egypt
Fundació Institut de Recerca de l'Hospital de la...

Completed

Adalimumab Biosimilar in Clinical Practice

Psoriasis

Spain
Janssen Research & Development, LLC

Completed

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

Psoriasis

United States
Nazarbayev University Medical Center
Eurasia Invest Ltd.; Ministry of Education and Science, Republic of Kazakhstan and other collaborators

Completed

Effect of Sublimated Mare Milk Supplement on Gut Microbiome in Psoriasis Patients

Psoriasis

Kazakhstan
Association pour la Recherche Clinique et Immunologique

Unknown

Role of Brodalumab in the Modulation of Gut Microbiome in Psoriatic Patients (BOMOGUMIP)

Psoriasis
Bristol-Myers Squibb

Completed

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

Psoriasis

United States, Germany, Australia, Canada, Japan, Latvia, Mexico, Poland
Derm Research, PLLC

Unknown

The Maintenance Effect of Enstilar Foam in Combination With Otezla

Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis

Psoriasis

United States
Pierre Fabre Dermo Cosmetique
Institut National de la Santé Et de la Recherche Médicale, France; Centre National...

Completed

Characterization and Functionality of Calcium Channels Cav1.4 of Th17 Lymphocytes in Human With Psoriasis

Psoriasis

France
Wake Forest University

Completed

Using an Internet Study to Improve Adherence for Psoriasis Patients

Psoriasis

United States
Bristol-Myers Squibb

Completed

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

Psoriasis

United States
AbbVie

Completed

A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy

Psoriasis

Germany
University of Southern California
Patient-Centered Outcomes Research Institute

Completed

Collaborative Connected Health (CCH) for PCORI (PCORI)

Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis

Psoriasis
Zhejiang University
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate

Psoriasis

China
Wake Forest University

Terminated

Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin

Psoriasis

United States
Cairo University

Unknown

Resolvin D1 in Psoriasis Before and After Narrowband UVB Phototherapy

Psoriasis

Egypt
University Hospital, Gentofte, Copenhagen

Completed

A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis

Psoriasis

Denmark
Bayer

Completed

1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat

Psoriasis

Germany
GlaxoSmithKline
PPD; Innovaderm Research Inc.; iCardiac; Algorithme

Withdrawn

A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects

Psoriasis
Atridia Pty Ltd.

Completed

A Study of SHR-1314 in Healthy Subjects

Psoriasis

Australia
Provectus Pharmaceuticals

Completed

A Phase 2 Study of Cellular and Immunologic Changes in the Skin of Subjects Receiving PH-10

Psoriasis

United States
Bayer

Terminated

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Psoriasis

Germany
Prism Pharma Co., Ltd.

Completed

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

Psoriasis

Germany
Bausch Health Americas, Inc.

Completed

A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab

Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

Psoriasis

United Kingdom
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) (TIPS)

Psoriasis
Chengdu PLA General Hospital

Unknown

Safety and Efficacy of Etanercept in Patients With Psoriasis

Psoriasis

China
Tufts Medical Center

Completed

Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis

Psoriasis

United States
Amgen

Completed

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis (REFINE)

Psoriasis

Canada
Almirall, S.A.

Completed

Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 (LAS41008)

Psoriasis

United Kingdom
Universitaire Ziekenhuizen KU Leuven
Pfizer

Completed

An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients (DERM)

Psoriasis
Centre Hospitalier Universitaire de Nice
Pfizer; Fotofinder

Completed

PASIMAT: Automatic Measure of PASI (PASIMAT)

Psoriasis
Amgen

Completed

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

Psoriasis
Fundación Pública Andaluza Progreso y Salud

Completed

Etanercept Survival in Elderly Population

Psoriasis

Spain
Centocor, Inc.

Completed

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Psoriasis
Wayne State University
Abbott

Terminated

Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis

Psoriasis

3

Subscribe